Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Positive clinical data from temozolomide trials presented at European oncology meeting

Sep. 16, 1998

Matrix completes enrollment in IntraDose trials

Sep. 16, 1998

Corixa's MUC-1 vaccine technology receives patent protection

Sep. 16, 1998

Hycamtin receives first approval for small cell lung cancer in Switzerland

Sep. 15, 1998

Onyx discovers another therapeutic virus for cancer therapy

Sep. 15, 1998

Antigestagenic steroid esters patented by Schering AG

Sep. 15, 1998

rAd/p21: an effective gene therapy approach for treating lung cancer

Sep. 15, 1998

Japanese researchers report progress in the gene therapy of gastric cancer

Sep. 14, 1998

FDA recommends full approval of first new treatment for metastatic colorectal cancer in 40 years

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...